Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Dec 15, 2025-- OmniAb, Inc. (NASDAQ: OABI) announces the launch of its new OmniUltra ™ platform, the industry’s first and only transgenic chicken engineered to express ultralong CDRH3 domains on a human antibody …